The role of aspirin provocation test in confirming aspirin hypersensitivity

K. Specjalski, M. Chelminska, J. Lata, I. Damps-Konstanska, K. Kuziemski, M. Niedoszytko, E. Jassem (Gdansk, Poland)

Source: Annual Congress 2006 - Diagnosis of allergy, asthma and allergic rhinitis
Session: Diagnosis of allergy, asthma and allergic rhinitis
Session type: Thematic Poster Session
Number: 3935
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Specjalski, M. Chelminska, J. Lata, I. Damps-Konstanska, K. Kuziemski, M. Niedoszytko, E. Jassem (Gdansk, Poland). The role of aspirin provocation test in confirming aspirin hypersensitivity. Eur Respir J 2006; 28: Suppl. 50, 3935

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The inhalation provocation test with sodium diclofenac for assessment of aspirin exacerbated respiratory diseases (AERD)
Source: Eur Respir J 2007; 30: Suppl. 51, 364s
Year: 2007

Application of basophil activation test for diagnosis of nsaid hypersensitivity
Source: Annual Congress 2009 - Inflammation and airways
Year: 2009


Distinct clinical and biochemical responses to aspirin provocation challenge
Source: Eur Respir J 2003; 22: Suppl. 45, 414s
Year: 2003

Basophil activation test as support for distinguishing between aspirin-induced asthma and allergic reaction to ASA
Source: Annual Congress 2011 - Diagnosis and treatment of inflammatory respiratory diseases
Year: 2011


Assessment of bronchoprovocation test positivity and response to montelukast theraphy in chronic urticaria patients
Source: Eur Respir J 2006; 28: Suppl. 50, 445s
Year: 2006

Safety and efficacy of inhaled mannitol as a bronchial provocation test in children
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011

Effect of antileukotriene therapy on methacholine challenge test in patients with mild asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 587s
Year: 2004

The course of aspirin-induced asthma may be helpful in predicting the type of response to aspirin
Source: Annual Congress 2008 - Asthma: growing understanding of influential factors
Year: 2008

Comparison of exercise provocation and induced sputum measurement in patients with positive methacholine provocation test
Source: Eur Respir J 2005; 26: Suppl. 49, 371s
Year: 2005

Methacoline challenge test as an evaluator of response to statins in bronchial hyperresponsiveness
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012

Clinical and biochemical differences between patients with aspirin-induced asthma/rhinitis
Source: Annual Congress 2005 - PG18 - Inter-relationships between upper and lower airway diseases
Year: 2005


The effect of immunosuppressives on the tuberculin skin test
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis
Year: 2008

The inhaled allergen challenge test
Source: Short video discussion 2022
Year: 2022

Hypertonic histamine challenge induced cough in assessing the treatment response to inhaled corticosteroid in asthma
Source: Annual Congress 2008 - Cough and airway hyperresponsiveness
Year: 2008

Protective effect of inhaled anticholinergic drugs in the methacholine test
Source: Eur Respir J 2007; 30: Suppl. 51, 619s
Year: 2007

Hypersensitivity pneumonitis caused by oral aspirin
Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases
Year: 2009


Does acute bronchodilator test is predictive of inhaled corticosteroid response in COPD/asthma patients?
Source: Annual Congress 2010 - Treatment options for asthma
Year: 2010

Esomeprazole 80 mg single-dose improves the bronchial response to MCh in non atopic GER-related asthma
Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population
Year: 2005


Inhaled budesonide suppresses airway and systemic eosinophilic inflammation in COPD. No predictive value of a prednisolone test treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 290s
Year: 2005